Scientific Programme (General) 2010

Please note that the programme below is preliminary. The invitation/confirmation process is ongoing, and invitations-to-be-confirmed (TBC) will be replaced by names continuously. Latest update: Wednesday 25th August 09:41

Sunday, November 14th

10.00-15.00

Meetings for other organisations

 

15.00-17.00

Update Committees meetings

 

16.00-18.00

Registration desk

 

18.00-20.00

Reception

 

20.00-22.00

Chairperson's and Speaker's dinner

 

 

 

 

Monday, November 15th

 

07.00-16.30

Registration desk

 

08.30-08.45

Welcome address and introduction
Nils Wahlgren, Stockholm, and Didier Leys, Lille

 

08.45-10.15

Session: Carotid endarterectomy vs angioplasty
Chairs: Jean-Louis Mas, Paris
Secretary: Konstantinos Kostulas, Stockholm

 

08.45-09.05

Carotid Stenting is as safe and as effective as carotid surgery in patients at risk for stroke - results from the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST)
Invited TBC

 
09.05-09.25 Carotid Endarterectomy should remain the treatment of choice for patients suitable for surgery, results from the International Carotid Stenting Study (ICSS)
Invited TBC
 

09.25-09.45

What is the overall impression of carotid endarterectomy vs stenting trials?
Peter Rothwell, Oxford

 

09.45-09.55

Presentation of draft statement
Konstantinos Kostulas

 

09.55-10.15

Consensus discussion and statement
Chaired by Jean-Louis Mas, Paris
Additional discussants: TBC

 

10.15-10.45

Special lecture: Title to be confirmed
Chair: Nils Wahlgren
Speaker: Takenori Yamaguchi, Osaka

 

10.45-11.15 Coffee Break  

11.15-12.15

Session: Cerebral artery dissection
Chair: Jacques De Keyser, Brussels Anna Czlonkowska, Warsaw /Secretary: Christina Sjöstrand, Stockholm

 

11.15-11.35

Management of extracranial artery dissections
Marie-Germaine Bousser, Paris

 
11.35-11.50 Management of intracranial artery dissections
Gert-Jan Luijckx, Groningen
 

11.50-12.00

Presentation of draft statement
Christina Sjöstrand, Stockholm

 

12.00-12.15

Consensus discussion and statement
Chaired by Jacques De Keyser, Brussels

 

12.15-13.15

Lunch and poster exhibition

 

13.15-14.35

Session: Prevention of stroke in atrial fibrillation
Chair: Gary Ford, Newcastle and Bo Norrving, Lund/Secretary: Mia von Euler, Stockholm

 

13.15-13.35 Dabigatran is superior to Warfarin in prevention of stroke in patients with atrial fibrillation - overall results of the RE-LY study
Invited TBC
 

13.35-13.55

Dabigatran is superior to Warfarin in secondary prevention of stroke in patients with atrial fibrillation - subgroup results of the RE-LY study
Christoph Diener, Essen

 

13.55-14.15

Warfarin may still be the better alternative
Didier Leys, Lille

 

14.15-14.25

Presentation of draft statement
Mia von Euler, Stockholm

 

14.25-14.40

Consensus discussion and statement
Chaired by Gary Ford, Newcastle

 

14.40-15.10

Coffee break

 

15.10-16.15

Session: Subarachnoid haemorrhage and aneurysms - new guidelines
Chair: Thorsten Steiner, Heidelberg ./Secretary: Michael Mazya, Stockholm

 

15.10-15.30 Presentations in this session to be confirmedT mmmmmmmmmmmmmm  
15.30-15.45 TIA is an emergency - admit to an acute stroke unit
Gary Ford, Newcastle
 
15.45-15.55 Presentation of draft statement
Jean-Luc af Geijerstam, Stockholm
 

15.55-16.15

Consensus discussion and statement
Chaired by Thorsten Steiner

 

16.15-16.25

Summary and closing of the first day of the meeting, original programme
Nils Wahlgren, Stockholm

 

16.25-17.00

Karolinska Stroke Award Ceremony
Ceremony in the presence of the President of Karolinska Institutet Harriet Wallberg-Henriksson

 
  All participants are welcome to the following satellite session:  

17.05-18.15

SITS investigators' open session
Chair: Niaz Ahmed, Stockholm
Open for all meeting participants

 
17.05-17.15 SITS as a global tool for stroke quality development and research - the new database
Nils Wahlgren, Stockholm
 
17.15-17.30 Helsinki,.world leading stroke centre in SITS: The pathway to minimal treatment delays
Lauri Soinne, Helsinki
 
17.30-17.45

Czech Republic, successful nation in SITS: Finding the optimal organisation for thrombolysis
Robert Mikulik, Brno

 
17.45-18.00 UK, successful nation in SITS
Gary Ford, Newcastle
 
18.00-18.15 Italy, successful nation in SITS: How to integrate iv thrombolysis with the stroke unit model
Danilo Toni, Rome
 

19.30

Gala Dinner

 

 

 

 

Tuesday, November 16th

 

08.30-08.35

Introduction to day 2

 

08.35-10.20

Session: Reperfusion therapy - intravenous thrombolysis
Chair: Markku Kaste, Helsinki/ Secretary: Nikolaos Kostulas, Stockholm

 

08.35-08.55

Extension of the time window for intravenous thrombolysis to 4.5 h, update on efficacy and safety based on pooled RCT and SITS data
Invited TBC

 

08.55-09.15 Extension of thrombolysis beyond a time window of 4.5 h: the role of multimodal imaging
Invited TBC
 
09.15-09.35 Can thrombolysis be exended to the very elderly, to all baseline severity grades and patients with diabetes and previous stroke - data from SITS and VISTA collaborations
Kennedy R Lees, Glasgow
 

09.35-09.55

Intracerebral haemorrhage after thrombolysis - prediction and outcome
Michael Mazya, Stockholm

 

09.55-10.05 Presentation of draft statement
Nikolaos Kostulas, Stockholm
 

10.05-10.20

Consensus discussion and statement
Chaired by TBC

 

10.20-10.50

Coffee break

 

10.50-11.10

Special lecture: Intravenous thrombolysis - a dynamic report from SITS 2003-2010
Speaker: Nils Wahlgren, Stockholm

 

11.10-12.10

Session: Reperfusion therapy - thrombectomy
Chair: Peter Ringleb, Heidelberg/..................................... Secretary: TBC
 
11.10-11.30 Thrombectomy is evidence.based treatment - state of the art
Invited TBC
 
11.30-11.45 Thrombectomy is not evidence-based treatment
Peter Schellinger, Minden
 
11.45-11.55 Presentation of draft statement
Invited TBC
 
11.55-12.10

Consensus discussion and statement
Chaired by Peter Ringleb, Heidelberg

 

12.10-13.05

Lunch and poster exhibition

 

13.05-13.30

Special lecture: Title to be confirmed
Speaker: Anne Alexandrov, Birmingham, AL

 

13.30-14.50

Session: Reperfusion therapy: Sonothrombolysis
Chair: David Russell, Oslo and László Csiba, Debrecen/ Secretary: Tiago Moreira, Stockholm, Discussant: TBC

 

13.30-13.50

Sonothrombolysis: current evidence and future perspectives
Andrei Alexandrov, Birmingham, AL

 

13.50-14.10 Sonothrombolysis, what can we hope for?
Stephen Meairs, Mannheim
 
14.10-14.20 Presentation of draft statement
Tiago Moreira, Stockholm
 

14.20-14.35

Consensus discussion and statement
David Russell, Oslo

 

14.35-15.05

Coffee break

 

15.10-17.05

Session: Management of intracerebral haemorrhage
Chair Thorsten Steiner, Heidelberg, Mikael Svensson, Stockholm /Secretary: Michael Mazya, Stockholm

 

15.10-15.25

Overview of intracerebral haemorrhage
Thorsten Steiner, Heidelberg

 

15.25-15.40 Imaging in ICH
Invited TBC
 

15.40-15.55

Status of surgical treatment of intracerebral haemorrhage
Invited TBC

 

16.55-16.10

Status of pharmacological treatment of intracerebral haemorrhage
Thorsten Steiner, Heidelberg

 

16.10-16.25 Blood pressure management in intracerebral haemorrhage
Invited TBC
 
16.25-16.40 Neuroprotection in intracerebral haemorrhage
Invited TBC
 
16.40-16.50 Presentation of draft statement
Michael Mazya, Stockholm
 
16.50-17.05

Consensus discussion and statement
Chaired by Thorsten Steiner, Heidelberg

 

17.05-17.15

Summary and closing of the meeting
Nils Wahlgren, Stockholm

 

 

Karolinska Stroke Update